Vericel Corporation
Industry
- Biotechnology
- Large Molecule
- Gene Therapy, Cell Therapy
- Pharmaceuticals
- Medical Devices
- Biomaterials
Other Names/Subsidiaries
- Aastrom Biosciences
- Genzyme Biosurgery
Latest on Vericel Corporation
Timing regulatory strategies with reimbursement has never been more important—particularly for complex therapies that require inpatient services and management. The CMS Inpatient Prospective Payment S
The global market for orthobiologics for musculoskeletal soft tissue replacement and regeneration is expected to reach $2.3bn by 2023, with a compound annual growth rate (CAGR) of 4.0%, according to "
Deals in May Cook Medical To Sell Ambu's Single-Use Duodenoscopes In The US Following FDA approval Ambu AS granted Cook Medical Inc. rights to distribute its single-use, disposable duodenoscope in
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Gilead Pays Goldfinch $55m U